This site is intended for health professionals only

COPD drug access widened


Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE

European regulators have expanded the number of patients eligible for treatment with GlaxoSmithKline’s chronic obstructive pulmonary disorder drug Seretide

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine